Fig. 5.
Representative photograph of particle residue (here, with 50% (w/w) bupivacaine microspheres 4 days after injection). Residue appearance was similar in all particle formulations and time points.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.